The joined meeting, organized by the iLDLTG and the BSHBPS of the Royal Belgian Society for Surgery (RBSS), is a unique opportunity for all surgeons, especially those practicing in Belgium and Europe, to exchange the most up-to-date information in the fields of advanced liver surgery and transplantation. It is also an opportunity to see and discuss with old friends as well as to meet younger colleagues.

This year, this biennial meeting will be located in Brussels, the heart of Europe, at Hotel Le Plaza.

The arching theme of the meeting is: “Excellence through versatility”.

MCI has been honoured with the task of the practical organization of the meeting. Our team will be there to assure that your involvement with this highly interesting meeting will be a success in all its facets. We feel very strongly that no medical congress can survive in time if this partnership is not carried by both sides.

As a Professional Congress Organizer, MCI’s main task is to ensure that the iLDLT—PGC BSHBPS meeting can be a catalyst for further contacts between the industry and the delegates.

With this sponsor brochure, we would like to start our cooperation and invite you to make a selection of the offered items that you would like to retain in your participation package.

Sponsor Brochure


SponsorApplication Form


SponsorTerms & Conditions


If you are interested by one (or more) of these opportunities, please fill in the Sponsorship Application Form and send it back to ILDLT2021@mci-group.com.

If you have any questions regarding Sponsorship or Exhibition, please contact us.



GC Pharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in South Korea, GC Pharma is the largest plasma protein product manufacturer in Asia and has been dedicated to quality healthcare solutions for more than half a century. Green Cross Corporation updated its corporate brand to GC Pharma in early 2018.

Established in 1970, SK Plasma specializes in plasma-derived medicine and plasma fractionation under the founding principles of “promoting human health and protecting environment.” In 2015, SK Plasma became an independent company in order to achieve global expansion. In order to respond to the rapidly increasing, both domestic and international, demand a most advanced new plasma fractionation plant was started in Andong (S.Kr) in 2018. Plasma derived products are essential to treat diseases, directly linked to human life, such as congenital immunodeficiency diseases and hemophilia. Besides plasma derivatives, SK Plasma also actively develops other pharmaceutical products. SK Plasma so plays a major role in creating social value by protecting human health.


The Section was created on April 28th, 2000 by a group of Belgian surgeons with a special interest and expertise in Hepato-Biliary and Pancreatic Surgery. This Section is a subgroup of the Royal Belgian Society for Surgery (RBSS). One member of the Section represents the Section in the Board of the RBSS. The official language is English.

At Johnson & Johnson Medical Devices Companies, we are using our breadth, scale and experience to reimagine the way healthcare is delivered and help people live longer, healthier lives.

In a radically changing environment, we are making connections across science and technology to combine our own expertise in surgery, orthopedics and interventional solutions with the big ideas of others to design and deliver physician and patient-centric products and solutions.

As pioneers in medical devices, we continually focus on elevating the standard of care – working to expand patient access, improve outcomes, reduce health system costs and drive value. We create smart, people-centered healthcare to help the patients we serve recover faster and live longer and more vibrantly.

We are in this for life.

As a  global  leader  in  medical  technology,  we  improve  the lives  and  health  of  millions of people each year — with our innovative therapies,  services,  and  solutions.  Learn  how we’re taking  healthcare Further,  Together at https://www.medtronic.com/uk-en/index.html

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2020 employed more than 100,000 people worldwide.


Corza Medical

Corza Medical’s mission is to aid and champion the surgical community with outstanding products and remarkable service that save time, money and effort. Uniting Surgical Specialties Corporation and TachoSil, we are a leading provider of medical devices serving surgeons and their teams, distributors and OEM partners around the world. With our expanding platform of industry-leading brands, including Quill™ barbed sutures, Sharpoint™ and Look™ surgical sutures, Sharpoint ophthalmic knives, the TachoSil fibrin sealant matrix, as well as Pearsalls and FSSB OEM solutions, Corza Medical delivers an exceptional customer experience and outstanding value to the entire surgical community.

HEPATOTRANSPLANT BRUSSELS was founded in 1997 as a common initiative of transplant surgeons and liver transplanted patients transplanted at the University Hospitals Saint-Luc, Université Catholique de Louvain (UCL). The association gives moral and psychological support to liver recipients, patients waiting for a new liver and their respective families. Yearly medical «grand public» conferences, cultural and social activites are organized. Beside the monthly magazine, social media platform and website (hepatotransplant.be/contact), the association informs its members about recent developments in the field of liver transplantation and procures scientific information related to liver diseases, liver transplantation and post-transplantation care. Basic and clinical research projects related to liver transplantation and donation are supported by the two-yearly Ruth Stassen-Offergelt grant.

Institut Georges Lopez, more often referred to as IGL, is a medical technology company specializing in the care of explanted organs and tissues. At IGL, we design, manufacture, and market products classified as drugs or medical devices, and intended for the treatment of patients with chronic organ diseases. With years of expertise and experience, IGL is proud to be regarded as a key player in its domain. IGL is headquartered in Lyon area (France), and consists of a network of subsidiaries located worldwide. This means we are never far from our customers and so can help them to meet their local challenges.